Best Doctors for Lung Cancer in Phoenix, Arizona
Top rated doctors for Lung Cancer trials
Find top doctors for Lung Cancer clinical trials in Phoenix, Arizona
Terence Sio, MD
Mayo Clinic- Arizona
5 years of reported clinical research
Panayiotis Savvides, MD
Mayo Clinic Hospital
4 years of reported clinical research
Kenneth Sakata, MD
Mayo Clinic Hospital
5 years of reported clinical research
View doctors based on their specific trial experience
Stage IV
Stage III
Terence Sio, MD
Mayo Clinic- Arizona
Panayiotis Savvides, MD
Mayo Clinic Hospital
Kenneth Sakata, MD
Mayo Clinic Hospital
Frequently Asked Questions
How do I find the best doctors near me?
There are 3 top ranked lung cancer doctors in Phoenix, Arizona on this page. The list includes specialists known for their experience and high success rates treating Lung Cancer.
Here are some leaders in Lung Cancer based on their past trial experience:Terence Sio, MDPanayiotis Savvides, MDKenneth Sakata, MD
What are the best research centers for Lung Cancer clinical trials in Phoenix, Arizona?
Major Centers for Lung Cancer Clinical Trials in Phoenix, Arizona
Mayo Clinic: A leading medical research center known for its extensive clinical trials program, including those focused on lung cancer.
Banner MD Anderson Cancer Center: Part of the Banner Health system, this center collaborates with the University of Texas MD Anderson Cancer Center in Houston to offer a wide range of cancer treatments and clinical trials.
Dignity Health – St. Joseph’s Hospital and Medical Center: This hospital is home to the University of Arizona Cancer Center at Dignity Health St. Joseph's, which conducts various cancer-related research studies and clinical trials.
Translational Genomics Research Institute (TGen): TGen focuses on applying genomic analysis and bioinformatics to translational research, including lung cancer studies.
What are the Symptoms of Lung Cancer?
Understanding Lung Cancer: Symptoms and Clinical Trials
Symptoms of Lung Cancer
Lung cancer, one of the most common types of cancer worldwide, can present a range of symptoms. It's important to remember that early stages may not show any signs at all. However, as the disease progresses, some noticeable symptoms might include:
Persistent Cough: A cough that doesn't go away or worsens over time.
Changes in Cough: This could be coughing more often or experiencing changes in the sound or severity of your cough.
Breathing Difficulties: Shortness of breath or wheezing during regular activities.
Chest Pain: Pain in the chest area that may intensify with deep breathing, coughing, or laughing.
Blood in Sputum (Phlegm): Noticing blood when you cough up phlegm from your lungs.
Hoarseness: Changes in voice tone or becoming hoarse without a clear reason.
Unexplained Weight Loss and Fatigue: Losing weight without trying accompanied by general tiredness.
If you notice any persistent changes to your health like these, it’s crucial to see a healthcare provider for an evaluation.
Clinical Trials on Lung Cancer
Clinical trials are research studies conducted with people who volunteer to test new treatments and therapies. These trials are essential for developing new methods to prevent, detect, diagnose, and treat lung cancer.
Types of Clinical Trials for Lung Cancer Include:
Prevention Trials: Focus on preventing lung cancer in healthy individuals or preventing it from returning after treatment.
Screening Trials: Aimed at finding effective ways to detect lung cancer early before symptoms appear.
Treatment Trials: Test new treatments such as innovative drugs, surgery techniques, radiation therapies or combinations thereof which could be more effective than current options.
Quality of Life Studies (Supportive Care): Explore approaches to improve comfort and quality of life for patients undergoing treatment.
Participation is always voluntary; participants have the right to withdraw from a study at any point if they choose.
For those considering participation in a clinical trial related to lung cancer - discussing this option with your healthcare team is vital. They can offer advice specific to your situation and help connect you with suitable clinical trials based on your condition and preferences.
What are the types of treatments available for Lung Cancer?
Treatment Options for Lung Cancer
1. Surgery
Wedge resection: Removes a small section of lung that contains the tumor along with a margin of healthy tissue.
Lobectomy: Removes an entire lobe of one lung.
Pneumonectomy: Removes an entire lung if cancer is extensive.
2. Radiation Therapy
Uses high-energy beams, like X-rays, to kill cancer cells.
Often used when surgery isn't an option or after surgery to target remaining cancer cells.
3. Chemotherapy
Involves drugs that kill cancer cells, usually given through the vein (intravenously) or as pills.
Can be used before surgery to shrink tumors or after to kill any lingering cancer cells.
4. Targeted Drug Therapy
Targets specific mutations within cancer cells to block their growth.
Used for cancers with certain genetic markers and often combined with chemotherapy.
5. Immunotherapy
Boosts the body's natural defenses to fight the cancer by targeting specific proteins on the surface of cancer cells.
Generally used for advanced stage lung cancers.
6. Stereotactic Body Radiotherapy (SBRT)
Also known as radiosurgery; a highly precise form of radiation therapy ideal for smaller, early-stage tumors not near vital organs.
Each treatment plan is personalized based on factors such as type and stage of lung cancer, overall health, and patient preferences. It's crucial to discuss all available options with healthcare providers who can guide decisions tailored specifically for each individual case.
What are some recent breakthroughs in clinical trials for Lung Cancer?
Recent Breakthroughs in Clinical Trials for Lung Cancer
1. Immunotherapy Enhancements
Key Development: New immunotherapies that boost the immune system's ability to fight lung cancer, especially non-small cell lung cancer (NSCLC), have shown significant success.
Impact: These treatments offer a more personalized approach, leading to longer survival times and improved quality of life for many patients.
2. Targeted Therapy Advances
Key Development: The development of drugs targeting specific genetic mutations within lung cancer cells, such as EGFR and ALK mutations.
Impact: Patients with these mutations can receive treatments tailored to their cancer's specific characteristics, often resulting in better outcomes compared to traditional chemotherapy.
3. Combination Therapies
Key Development: Combining targeted therapies with immunotherapies or chemotherapy has proven more effective than single-method treatments in some trials.
Impact: This strategy can significantly extend survival and reduce side effects for patients with advanced lung cancer.
4. Early Detection Techniques
Key Development: Research into early detection methods, including low-dose CT scans for high-risk individuals, has led to earlier diagnosis and treatment initiation.
Impact: Early detection is crucial for improving survival rates since it allows for treatment at a less advanced stage of the disease.
5. KRAS Inhibitors
Key Development: The discovery and clinical testing of inhibitors targeting KRAS gene mutations present in a subset of lung cancers.
Impact: For years considered "undruggable," these new inhibitors provide hope by specifically targeting one of the most common mutations found in NSCLC.
These breakthroughs represent exciting progress in the battle against lung cancer, offering new options and hope where there was previously limited potential for treatment improvement.
Which Lung Cancer specialists in Phoenix, Arizona are most well-regarded?
In Phoenix, Arizona, the most well-regarded lung cancer specialists include:
Dr. Terence Sio from Mayo Clinic- Arizona
Dr. Panayiotis Savvides from Mayo Clinic Hospital
Dr. Kenneth Sakata from Mayo Clinic Hospital
These doctors are highly esteemed for their expertise in lung cancer treatment and research, and they are affiliated with the renowned Mayo Clinic, known for its comprehensive care and innovative approaches to cancer therapy.
How to choose the best doctor for Lung Cancer?
Choosing the best doctor for Lung Cancer trials involves several considerations to ensure you receive the best possible care and access to the most advanced treatments. Here is a guide to help you in this process:
1. Specialization and Experience: Look for an oncologist who specializes in Lung Cancer. The more experience a doctor has with Lung Cancer, the better.
2. Affiliation with Research Institutions: Doctors affiliated with major cancer centers or research institutions are often more likely to be involved in clinical trials and stay updated on the latest treatments and technologies.
3. Access to Clinical Trials: Inquire about the availability of clinical trials and how the doctor incorporates them into their treatment plans. A doctor actively involved in trials may offer more innovative treatment options.
4. Patient Outcomes and Reviews: Research patient outcomes and reviews if available. High success rates and positive reviews can be indicative of quality care.
5. Communication Skills: Choose a doctor who is willing to spend time answering your questions, explains complex medical information clearly, and listens to your concerns. Good communication is crucial for effective treatment.
6. Second Opinion: Don't hesitate to seek a second opinion, especially if you have reservations about the recommended treatment plan or want to explore other options.
What is the best way to schedule an appointment with the doctors?
You will need to apply for a specific clinical trial. Click into any doctor's profile to see their trials.
More Lung Cancer trials
Other active clinical trials studying Lung Cancer on our platform.
SREC + Nicotine Lozenge
ABBV-514 + Budigalimab
Sonidegib + Pembrolizumab
Personalized Chemoradiation
Immunotherapy + Radiation
Aurora A Kinase Inhibitor + Osimertinib
PrOMOTE Program
Tele-Navigation
ABBV-400
Chemotherapy + Nivolumab
Intravenous and Intrathecal Nivolumab
Pembrolizumab Dosing Schedules
Osimertinib + Chemotherapy
Fecal Microbiota Transplantation
DS-8201a + Pembrolizumab
Capmatinib Safety
ADP-A2M4CD8 + Immunotherapy
Lorlatinib vs Crizotinib
Radiation Therapy Techniques
Chemotherapy + Durvalumab
Durvalumab + Tremelimumab ± Chemotherapy
Pre-Surgical Respiratory Muscle Training
Poziotinib
Post-Surgery Stereotactic Body Radiation
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.